Gilead Sciences reported $2.88B in Pre-Tax Profit for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
ALKERMES ALKS:US USD 136K 7.25M
Alnylam Pharmaceuticals ALNY:US USD -329357000 54.68M
Biogen BIIB:US USD 821M 53.8M
Bluebird Bio BLUE:US USD -76513000 16.99M
Coherus Biosciences CHRS:US USD -86650000 36.5M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Intercept Pharmaceuticals ICPT:US USD -104087000 83.77M
Johnson & Johnson JNJ:US USD 8.07B 98M
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Ptc Therapeutics PTCT:US USD -127208000 21.49M
Regeneron Pharmaceuticals REGN:US USD 1.45B 140.6M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Teva Pharmaceutical Industries TEVA:US USD 769M 62M
United Therapeutics UTHR:US USD 312.5M 161.9M
YTE INCY:US USD 178.22M 131.36M